DEPARTMENT OF ERROR The Lancet Volume 363, Issue 9427, (June 2004)   The Lancet  Volume 363, Issue 9427, (June 2004) DOI: 10.1016/S0140-6736(04)16524-0 Copyright © 2004 Elsevier Ltd Terms and Conditions

Figure 2 ANXA1 expression in hairy cell leukaemia (A), splenic lymphoma with villous lymphocytes (B, C), and variant hairy cell leukaemia (D, E, F) A Marked bone-marrow infiltration by ANXA1-positive hairy cell leukaemia cells. Arrow points to leukemia cell with prominent hairy projections (bone marrow paraffin section). (B) Arrow shows a DBA44-positive leukaemic cell (perpheral blood cytospin). (C) Arrow shows absence of ANXA1 in leukaemic cell (perpheral blood cytospin). (D) Leukaemic cells show wide cytoplasm and prominent nucleoli (arrow). (E) Nucleolated tumour cells positive for DBA44 (arrow). (F) Neoplastic cell are ANXA1-nagative' an ANXA1-positive neutrophil (arrow) serves as a positive control. Spleen paraffin sections used for variant hairy cell leukaemia. The Lancet 2004 363, DOI: (10.1016/S0140-6736(04)16524-0) Copyright © 2004 Elsevier Ltd Terms and Conditions